BlackRock, Inc.

Position in VTRS — Viatris Inc

CIK 2012383 New York, NY

Position in VTRS

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$1,139,700,941

+$58,731,977 QoQ

Shares Held

84,359,804

-2.8% QoQ

Ownership

7.24%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 92.74467612561072.ToString("F0")% Shared 0.ToString("F0")% None 7.255323874389277.ToString("F0")%

Healthcare · as of Mar 31, 2026

BlackRock, Inc. holds $19,745,764,999 across 67 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	35,584,312	$4,206,421,510
2	UTHR	UNITED THERAPEUTICS Corp	5,399,649	$3,201,883,855
3	TEVA	Teva Pharmaceutical Industries Ltd	65,136,464	$1,961,910,288
4	NBIX	Neurocrine Biosciences Inc	13,385,607	$1,763,419,854
5	VTRS	Viatris Inc This page	84,359,804	$1,139,700,941
6	ELAN	Elanco Animal Health Inc	47,622,630	$1,139,609,527
7	ALKS	Alkermes plc.	28,314,410	$1,001,197,527
8	LNTH	Lantheus Holdings, Inc.	8,183,193	$620,695,182

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,139,700,941	84,359,804	-2.8%	Shares	Sole	2026-05-13
2025-12-31	$1,080,968,964	86,824,817	+5.9%	Shares	Sole	2026-02-12
2025-09-30	$811,401,417	81,959,740	-1.1%	Shares	Sole	2025-11-12
2025-06-30	$739,950,935	82,861,248	-14.6%	Shares	Sole	2025-08-12
2025-03-31	$845,083,881	97,024,557	+3.1%	Shares	Sole	2025-05-02
2024-12-31	$1,171,943,476	94,132,007	+0.1%	Shares	Sole	2025-02-07
2024-09-30	$1,091,689,183	94,030,077	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.